Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 13, Issue 7, 2015, Pages 847-856

  Pfister, David G ^a   Spencer, Sharon ^b   Brizel, David M ^c   Burtness, Barbara ^d   Busse, Paul M ^e   Caudell, Jimmy J ^f   Cmelak, Anthony J ^g   Colevas, A Dimitrios ^h   Dunphy, Frank ^c   Eisele, David W ⁱ   Foote, Robert L ^j   Gilbert, Jill ^g   Gillison, Maura L ^k   Haddad, Robert I ^l   Haughey, Bruce H ^m   Hicks, Wesley L ⁿ   Hitchcock, Ying J ^o   Jimeno, Antonio ^p   Kies, Merrill S ^q   Lydiatt, William M ^r   Maghami, Ellie ^s   McCaffrey, Thomas ^f   Mell, Loren K ^t   Mittal, Bharat B ^u   Pinto, Harlan A ^h   Ridge, John A ^v   Rodriguez, Cristina P ^w   Samant, Sandeep ^x   Shah, Jatin P ^a   Weber, Randal S ^q   Wolf, Gregory T ^y   Worden, Frank ^y   Yom, Sue S ^z   McMillian, Nicole ^aa   Hughes, Miranda ^aa   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c DUKE CANCER INSTITUTE   (United States)

^d YALE CANCER CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g VANDERBILT INGRAM CANCER CENTER   (United States)

^h STANFORD CANCER INSTITUTE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j MAYO CLINIC CANCER CENTER   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l Dana Farber Brigham and Women's Cancer Center   (United States)

^m BARNES JEWISH HOSPITAL   (United States)

ⁿ ROSWELL PARK CANCER INSTITUTE   (United States)

^o UNIVERSITY OF UTAH   (United States)

^p University of Colorado Cancer Center   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^r UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^s CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^t UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^u NORTHWESTERN UNIVERSITY   (United States)

^v FOX CHASE CANCER CENTER   (United States)

^w SEATTLE CANCER CARE ALLIANCE   (United States)

^x UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^y UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^z UNIVERSITY OF CALIFORNIA   (United States)

^aa National Comprehensive Cancer Network   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTINUING EDUCATION; HEAD AND NECK CANCER; HUMAN; INTROSPECTION; ION THERAPY; MEDICAL EDUCATION; MEDICAL SOCIETY; NEUTRON THERAPY; PRACTICE GUIDELINE; PROTON THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALIVARY GLAND CANCER; UNITED STATES; HEAD AND NECK NEOPLASMS; NEUTRON CAPTURE THERAPY; PROCEDURES;

CARBON; HEAVY ION;

CARBON; GUIDELINES AS TOPIC; HEAD AND NECK NEOPLASMS; HEAVY ION RADIOTHERAPY; HEAVY IONS; HUMANS; NEUTRON CAPTURE THERAPY; PROTON THERAPY;

EID: 84938055154     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2015.0102     Document Type: Article

References (72)

1. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and prevention. BMJ 2010;341:c4684.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-4301.
3. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105:175-201.
4. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550-4559.
5. Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012;30(Suppl 5):F34-54.
6. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
7. Cohan DM, Popat S, Kaplan SE, et al. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009;17:88-94.
8. Centers for Disease C, Prevention. Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012;61:258-261.
9. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-136.
10. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 2011;37:511-519.
11. Ratko TA, Douglas GW, de Souza JA, et al. Radiotherapy Treatments for Head and Neck Cancer Update. Rockville, MD: Agency for Healthcare Research and Quality (US); 2014.
12. Hunter KU, Schipper M, Feng FY, et al. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patientreported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys 2013;85:935-940.
13. Lohia S, Rajapurkar M, Nguyen SA, et al. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 2014;140:331-337.
14. Kam MK, Leung S-F, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-4879.
15. Baxi SS, Sher DJ, Pfister DG. Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care. Am Soc Clin Oncol Educ Book 2014:e296-303.
16. Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;72:747-755.
17. Kocak-Uzel E, Gunn GB, Colen RR, et al. Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 2014;111:281-288.
18. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-1439.
19. Brown PD, Foote RL, McLaughlin MP, et al. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys 2005;63:1361-1367.
20. Citrin D, Mansueti J, Likhacheva A, et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74:1040-1046.
21. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013;31:845-852.
22. Awan MJ, Mohamed AS, Lewin JS, et al. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol 2014;50:746-752.
23. Sharma J, Dougherty AH. Recurrent syncope in a cancer patient: a case report and review of the literature. Cardiol Res Pract 2011;2011:678237.
24. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;84:1198-1205.
25. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys 2014;89:292-302.
26. Trikalinos TA, Terasawa T, Ip S, et al. Particle Beam Radiation Therapies for Cancer. Rockville, MD: Agency for Healthcare Research and Quality (US); 2009.
27. Mitin T, Zietman AL. Promise and pitfalls of heavy-particle therapy. J Clin Oncol 2014;32:2855-2863.
28. Johnstone PA, Kerstiens J. Doing poorly by doing good: the bottom line of proton therapy for children. J Am Coll Radiol 2014;11:995-997.
29. Schlaff CD, Krauze A, Belard A, et al. Bringing the heavy: carbon ion therapy in the radiobiological and clinical context. Radiat Oncol 2014;9:88.
30. Catterall M. First randomized clinical trial of fast neutrons compared with photons in advanced carcinoma of the head and neck. Clin Otolaryngol Allied Sci 1977;2:359-372.
31. Blake PR, Catterall M, Errington RD. Treatment of malignant melanoma by fast neutrons. Br J Surg 1985;72:517-519.
32. Maor MH, Errington RD, Caplan RJ, et al. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial. Int J Radiat Oncol Biol Phys 1995;32:599-604.
33. MacDougall RH, Orr JA, Kerr GR, Duncan W. Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial. BMJ 1990;301:1241-1242.
34. Laramore GE, Krall JM, Griffin TW, et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 1993;27:235-240.
35. Griffin BR, Laramore GE, Russell KJ, et al. Fast neutron radiotherapy for advanced malignant salivary gland tumors. Radiother Oncol 1988;12:105-111.
36. Stannard C, Vernimmen F, Carrara H, et al. Malignant salivary gland tumours: can fast neutron therapy results point the way to carbon ion therapy? Radiother Oncol 2013;109:262-268.
37. Glaholm J, Harmer C. Soft-tissue sarcoma: neutrons versus photons for post-operative irradiation. Br J Radiol 1988;61:829-834.
38. Withers HR, Thames HD, Peters LJ. Biological bases for high RBE values for late effects of neutron irradiation. Int J Radiat Oncol Biol Phys 1982;8:2071-2076.
39. Glenny AM, Furness S, Worthington HV, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy. Cochrane Database Syst Rev 2010:CD006387.
40. Demizu Y, Fujii O, Iwata H, Fuwa N. Carbon ion therapy for early-stage non-small-cell lung cancer. Biomed Res Int 2014;2014:727962.
41. Gerweck LE, Kozin SV. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol 1999;50:135-142.
42. Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010;95:3-22.
43. Hutcheson K, Lewin J, Garden A, et al. Early experience with IMPT for the treatment of oropharyngeal tumors: Acute toxicities and swallowingrelated outcomes. Int J Radiat Oncol Biol Phys 2013;87:S604.
44. Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT). Accessed April 27, 2015. .Available at: http://clinicaltrials.gov/show/NCT01893307.
45. Miller RC, Lodge M, Murad MH, Jones B. Controversies in clinical trials in proton radiotherapy: the present and the future. Semin Radiat Oncol 2013;23:127-133.
46. Zenda S, Kawashima M, Nishio T, et al. Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys 2011;81:135-139.
47. th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 2012;83:704-711.
48. Demizu Y, Fujii O, Terashima K, et al. Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol 2014;190:186-191.
49. Fuji H, Yoshikawa S, Kasami M, et al. High-dose proton beam therapy for sinonasal mucosal malignant melanoma. Radiat Oncol 2014;9:162.
50. Allen AM, Pawlicki T, Dong L, et al. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol 2012;103:8-11.
51. Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer 2005;93:849-854.
52. Zenda S, Kawashima M, Arahira S, et al. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up. Int J Clin Oncol 2014.
53. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl 2):57-63.
54. Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol 2014;15:1027-1038.
55. Tokuuye K, Akine Y, Kagei K, et al. Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 2004;180:96-101.
56. Noel G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 2003;179:241-248.
57. Santoni R, Liebsch N, Finkelstein DM, et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys 1998;41:59-68.
58. Slater JD, Yonemoto LT, Mantik DW, et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 2005;62:494-500.
59. Chan A, Liebsch L, Deschler D, et al. Proton radiotherapy for T4 nasopharyngeal carcinoma [abstract]. J Clin Oncol 2004;22(Suppl):Abstract 5574.
60. Resto VA, Chan AW, Deschler DG, Lin DT. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008;30:222-229.
61. Chen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007;69:141-147.
62. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience. Int J Radiat Oncol Biol Phys 2007;67:691-702.
63. Frank SJ, Cox JD, Gillin M, et al. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys 2014;89:846-853.
64. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006;80:263-267.
65. Zenda S, Kohno R, Kawashima M, et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011;81:1473-1478.
66. Fitzek MM, Thornton AF, Varvares M, et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 2002;94:2623-2634.
67. Patel S, Kostaras X, Parliament M, et al. Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Curr Oncol 2014;21:251-262.
68. Mizoe JE, Hasegawa A, Jingu K, et al. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 2012;103:32-37.
69. Schulz-Ertner D, Nikoghosyan A, Jakel O, et al. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. Int J Radiat Oncol Biol Phys 2003;56:391-398.
70. Mizoe JE, Tsujii H, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358-364.
71. Kamada T, Tsujii H, Blakely EA, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol 2015;16:e93-e100.
72. Rieken S, Habermehl D, Nikoghosyan A, et al. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys 2011;81:e793-801.